BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect
Status:
Completed
Trial end date:
2019-02-11
Target enrollment:
Participant gender:
Summary
This single center, double-blind, randomized study with up to 11 treatment groups evaluates
the safety and tolerability, pharmacokinetics, relative bioavailability and food effect of
single ascending doses of BAY2328065